title: HMG-CoA reductase inhibitors and bile lithogenicity: cholesterol supersaturation or nucleation defect?
authors.affiliation: St George's Hospital Medical School, London, UK.
authors.forename: H A
authors.initials: HA
authors.lastname: Ahmed
authors.forename: R P
authors.initials: RP
authors.lastname: Jazrawi
authors.forename: T C
authors.initials: TC
authors.lastname: Northfield
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D001646:Bile / Q000737:chemistry / Q000187:drug effects / Q000502:physiology*; D002769:Cholelithiasis / Q000201:enzymology / Q000209:etiology* / Q000517:prevention & control; D002784:Cholesterol / Q000737:chemistry / Q000502:physiology*; D003460:Crystallization; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
chemical_list: D000924:Anticholesteremic Agents; D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol